About CRBio
Established in 2007, CRBio, the Clinical Research & Biosciences division of RA Chem Pharma Ltd, is a Hyderabad, India-based regulatory class CRO.
The facility is spread over 20,000 sq.ft. in well laid out areas in the operations such as Clinical, Bioanalytical, Pharmacokinetic & Statistical, QA & RA, QC. With 4 full time doctors, the paramedical staff, clinics consist of 72 beds segregated into 3 independent clinics and with a 3000 volunteer database, with a state of the art bioanalytical laboratory with 4 LCMSMS, having over 50 methods with most of them validated, storage -86 & -30 deep freezers.
Submissions have been made to world reputed regulatory agencies such as USFDA, UK MHRA, Health Canada, EMEA, MoH Turkey, BPFK, Malaysia, PAHO, DCGI.
In a short span of 3 years, CRBio, which is independent in all its true sense, unaffiliated, has completed over 150 BA/BE projects. Growth plans are initiated when CRBio has forayed into patient population studies in the areas of oncology and anti-psychotic bioequivalence projects. Plans are on the anvil and CRBio is likely to foray into POC, CEP, pre-clinical and late stage clinical trials in a progressive manner. CRBio, acts as a catalyzer to sponsor’s innovative initiatives and is more like a partner to sponsor’s clinical trial requirements. Hence, the support is on a continuous basis and starts with the project and continues post project, both in evaluations and in query resolutions.
